Loading...
Reference tools for evidence, risk, and access. Aimed at peptide literacy and risk intelligence — not at producing personalised dosing, stack recommendations, or purchase suggestions. See our editorial position for why.
Filter peptides by published evidence grade, UK regulatory status, and sport-doping risk. Points to research pages — does not produce personalised peptide suggestions.
OpenLook up a peptide against WADA and UKAD prohibited categories. Reference only — not a substitute for a TUE process or anti-doping advice.
OpenCommon marketing claims about peptides, sorted by what the evidence actually shows.
OpenRed-flag wording used by clinics, sellers, and influencers — and what each phrase actually does or doesn't mean.
OpenThe combinations most commonly promoted as “stacks” — and what the evidence base does and doesn't show. Replaces the previous stack-builder.
OpenNHS and private routes to licensed weight-management GLP-1s (Wegovy, Mounjaro, Saxenda). Access education, not a price comparison.
OpenWhether you may meet NICE criteria for NHS Wegovy or Mounjaro. Reference indication only — not a substitute for a clinical assessment.
OpenHow researchers calculate reconstitution concentration, injection volume, and vial longevity. Generic arithmetic only — no peptide presets, no personalised dose output.
OpenPre-purchase 10-check tool for a UK pharmacy or online clinic. Computes a red-flag score from GPhC / prescriber / supply-route checks. No data leaves your browser.
OpenEducational triage if you suspect a counterfeit GLP-1 pen. Routes you to the right action: pharmacist / Yellow Card / NHS 111 / 999. Safety-only.
OpenPrintable prompt builder for a UK GP, specialist, or pharmacist appointment about peptides or GLP-1 medicines. Pick the questions, symptoms, and disclosures relevant to you.
OpenManually-curated chronological feed of MHRA / NICE / EMA / WADA / DHSC updates relevant to peptides and GLP-1 medicines.
OpenInternal editorial tool — apply the A–E grading methodology consistently. Study type + species + sample + endpoint + regulatory + AE evidence → grade.
OpenInternal editorial QA tool — score a citation before it goes into a page. Source type + recency + CoI + retraction + last-checked → grade and action.
OpenWe have removed the previous personalised Peptide Finder (redirected to Evidence Explorer), the operational Dosage Calculator (replaced with a maths explainer), the Stack Builder (replaced with the Claim Interaction Explorer), the multi-pharmacy Price Comparison (replaced with the GLP-1 Access Explainer), and My Pep Log (the injection-tracking PWA, fully removed). The pivot is from peptide enablement to peptide literacy and risk intelligence — see the notices on each replaced page for the full reasoning.